Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|June 4, 2021
Challenges Posed by Immune Responses to AAV Vectors: Addressing Root CausesBradley A Hamilton, J Fraser WrightHuman Gene Therapy|May 15, 2009
Transient transfection methods for clinical adeno-associated viral vector productionJ Fraser WrightBiotechnology Journal|November 4, 2020
Quality Control Testing, Characterization and Critical Quality Attributes of Adeno-Associated Virus Vectors Used for Human Gene TherapyJ Fraser WrightBiomedicines|May 27, 2017
Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk AssessmentJ Fraser WrightMolecular Therapy. Methods & Clinical Development|August 28, 2023
Erratum: AAV vector production: Troublesome host innate responses in another settingJ Fraser WrightMethods in Molecular Biology (Clifton, N.J.)|May 19, 2011
Vector characterization methods for quality control testing of recombinant adeno-associated virusesJ Fraser Wright, Olga ZelenaiaCurrent Gene Therapy|August 18, 2010
Manufacturing and regulatory strategies for clinical AAV2-hRPE65J Fraser Wright, Jennifer Wellman, Katherine A HighHuman Molecular Genetics|November 1, 2015
Progress and challenges in viral vector manufacturingJohannes C M van der Loo, J Fraser WrightCurrent Opinion in Drug Discovery & Development|April 3, 2003
Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vectorJ Fraser Wright, Guang Qu, Chunlin Tang, et al.Research and Practice in Thrombosis and Haemostasis|September 6, 2021
The intersection of vector biology, gene therapy, and hemophiliaLeszek Lisowski, Janice M Staber, J Fraser Wright, et al.Pageof 7